Pnc Financial Services Group, Inc. Sorrento Therapeutics, Inc. Transaction History

Pnc Financial Services Group, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.74 - $1.83 $1,465 - $3,623	-1,980 Reduced 96.12%	80 $0
Q3 2022 Nov 10, 2022	SELL	$1.51 - $2.88 $24,160 - $46,080	-16,000 Reduced 88.59%	2,060 $3,000
Q2 2022 Aug 12, 2022	BUY	$1.24 - $2.33 $18,600 - $34,950	15,000 Added 490.2%	18,060 $36,000
Q4 2021 Feb 11, 2022	SELL	$4.65 - $7.23 $10,611 - $16,498	-2,282 Reduced 42.72%	3,060 $14,000
Q2 2021 Aug 06, 2021	BUY	$6.35 - $10.0 $12,585 - $19,820	1,982 Added 58.99%	5,342 $51,000
Q1 2021 May 07, 2021	SELL	$7.03 - $16.51 $10,994 - $25,821	-1,564 Reduced 31.76%	3,360 $27,000
Q4 2020 Feb 12, 2021	SELL	$5.76 - $11.95 $10,229 - $21,223	-1,776 Reduced 26.51%	4,924 $33,000
Q3 2020 Nov 06, 2020	SELL	$6.17 - $18.82 $149,320 - $455,462	-24,201 Reduced 78.32%	6,700 $74,000
Q2 2020 Aug 07, 2020	BUY	$1.73 - $6.76 $53,458 - $208,890	30,901 New	30,901 $194,000
Q4 2018 Feb 08, 2019	SELL	$2.01 - $4.24 $9,044 - $19,080	-4,500 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$4.5 - $9.95 $20,250 - $44,775	4,500 New	4,500 $0

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.